-
Retirement Simplified
-
Calculators
Knowledge Centre
- Public Provident Fund
- NPS Reforms 2025
- EPF Rule Changes
- NPS vs Mutual Funds
- Multiple Scheme Framework (MSF)
- Wealth Creation and Legacy Planning
- Retirement Planning Under the Old & New Tax Regime
- Why Thinking Beyond FDs Is Important
- Retirement Corpus Planning
- Portfolio Diversification
- Senior Citizen Community Living in India
- View All
Who we are
ICICI Prudential Nifty Pharma Index Fund-idcw
Latest AUM
₹ 104.7 Cr.
NAV as on 12 may, 2026
₹ 18.04
Fund Details
Portfolio Composition Analysis
Sector Allocations
Portfolio Updated on: 12 may, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 22.89% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 23.17% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 21.81% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 22.05% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 22.18% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 22.18% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 21.38% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 21.97% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 21.61% |
Debt & Credit Risk Analysis
| Alpha | -1.77% |
| Beta | 0.96% |
| Sharpe Ratio | 0.90% |
| Standard Deviation | 16.80% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 6.25% | NA | 6.12% |
| 6 Months | 5.16% | NA | 12.92% |
| 9 Months | 8.93% | NA | 4.47% |
| 1 Year | 12.50% | 12.50% | 6.04% |
| 2 Years | 26.77% | 12.59% | 24.93% |
| 3 Years | 86.36% | 23.06% | 25.71% |
Historical NAV
| Date | NAV |
|---|---|
| 12 May 2026 | ₹18.04 |
| 11 May 2026 | ₹18.29 |
| 08 May 2026 | ₹18.24 |
| 07 May 2026 | ₹18.26 |
| 06 May 2026 | ₹18.24 |
| 05 May 2026 | ₹17.83 |
| 04 May 2026 | ₹17.76 |
| 30 Apr 2026 | ₹17.61 |
| 29 Apr 2026 | ₹17.60 |
| 28 Apr 2026 | ₹17.53 |
| 27 Apr 2026 | ₹17.54 |
| 24 Apr 2026 | ₹17.09 |
| 23 Apr 2026 | ₹17.40 |
| 22 Apr 2026 | ₹17.00 |
| 21 Apr 2026 | ₹16.99 |
| 20 Apr 2026 | ₹17.00 |
| 17 Apr 2026 | ₹17.03 |
| 16 Apr 2026 | ₹17.01 |
| 15 Apr 2026 | ₹16.99 |
| 13 Apr 2026 | ₹16.74 |
| 10 Apr 2026 | ₹16.79 |
| 09 Apr 2026 | ₹16.76 |
| 08 Apr 2026 | ₹16.66 |
| 07 Apr 2026 | ₹16.56 |
| 06 Apr 2026 | ₹16.54 |
| 02 Apr 2026 | ₹16.52 |
| 01 Apr 2026 | ₹16.67 |
| 31 Mar 2026 | ₹16.84 |
| 30 Mar 2026 | ₹16.84 |
| 27 Mar 2026 | ₹17.10 |
Portfolio Updated on: 13 May, 2026
Fund Growth & Size Analysis
Compare Mutual funds
ICICI Prudential Nifty Pharma Index Fund-idcw Returns Comparison
Compare ICICI Prudential Nifty Pharma Index Fund-idcw with any MF,
EYF, stock or index
No funds found for your search.
ICICI Prudential Nifty Pharma Index Fund-idcw is one Equity mutual fund offered by ICICI Prudential Mutual Fund. Launched on 14 Dec 2022, the fund aims Long term wealth creation solution. An index fund that seeks to track returns by investing in a basket of Nifty Pharma Index stocks and aims to achieve returns of the stated index, subject to tracking error. It manages assets worth ₹104.7 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.05%.
Ashwini Shinde has experience Prior to Joining the ICICI Pru Mutual Fund he has worked with ICICI Pru AMC Treasury Mutual Fund Operations,
Nishit Patel has experience Prior to joining ICICI Prudential Mutual fund, he has worked with K.K.Dand & Co.
Kayzad Eghlim has experience Prior to joining ICICI Prudential AMC he has worked with IDFC Investment Advisors Ltd., Prime Securities and Canara Robeco Mutual Fund.
- Sharpe Ratio: 0.90%
- Standard Deviation: 16.80%
- Beta: 0.96%
- Alpha: -1.77%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under ICICI Prudential Nifty Pharma Index Fund-idcw stand at approximately ₹ 104.7 crore.
The ICICI Prudential Nifty Pharma Index Fund-idcw has delivered the following short-term performance:
- 3 Months Return: 6.25%
- 6 Months Return: 5.16%
The historical growth of the ICICI Prudential Nifty Pharma Index Fund-idcw is reflected through its CAGR returns:
- 3 Year CAGR: 23.06%
- Return Since Launch: 18.88%
The portfolio of ICICI Prudential Nifty Pharma Index Fund-idcw is distributed across different asset classes as follows:
- Equity: 99.94%
- Other Assets: 0.06%
The ICICI Prudential Nifty Pharma Index Fund-idcw is managed by Kayzad Eghlim, representing ICICI Prudential Mutual Fund.
The ICICI Prudential Nifty Pharma Index Fund-idcw investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of ICICI Prudential Nifty Pharma Index Fund-idcw include:
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 22.89% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 23.17% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 21.81% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 22.05% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 22.18% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 22.18% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 21.38% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 21.97% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 21.61% of the portfolio
Major sector exposures in ICICI Prudential Nifty Pharma Index Fund-idcw are:
- Healthcare – accounts for 275.31% of the portfolio
